PFAS and Testicular Cancer: Highest Relative Risk
Testicular cancer — specifically testicular germ cell tumors — has the highest relative risk of any cancer associated with PFAS exposure. The meta-analysis by Mastrantonio et al. (2023) found a relative risk of 2.22 for testicular cancer among individuals with high PFAS exposure, meaning they are more than twice as likely to develop the disease compared to unexposed individuals. This is the strongest relative risk ratio of any PFAS-cancer association, exceeding even kidney cancer (RR=1.74).
The C8 Science Panel determined a "probable link" between PFOA exposure and testicular cancer based on the 69,000-person Mid-Ohio Valley study. The panel found a statistically significant dose-response relationship: residents with higher PFOA blood levels had progressively higher rates of testicular cancer. The subsequent C8 bellwether trials resulted in jury verdicts of $5.1 million (Freeman, 2016) and $12.5 million (Wolf, 2016) for testicular cancer caused by PFOA exposure — establishing that juries value testicular cancer claims highly.
Testicular cancer is most common in men ages 15 to 35, making it particularly relevant for military personnel and firefighters who were exposed to AFFF early in their careers. Young service members stationed at contaminated bases during their teens and twenties may have developed testicular cancer during the peak vulnerability window. Despite the seriousness of the diagnosis, testicular cancer has one of the highest cure rates of any cancer, with greater than 95% five-year survival even at advanced stages.
Building a Testicular Cancer AFFF Claim
Testicular cancer claims in the AFFF litigation require documentation of PFAS exposure and a pathologically confirmed diagnosis. Military service records showing assignment to a contaminated base, fire department employment records documenting AFFF use during training, or residential history in a contaminated community establish the exposure pathway. Medical records including the pathology report, staging information, and treatment history document the injury.
The C8 bellwether verdicts provide a strong precedent for testicular cancer case valuations. The $5.1 million Freeman verdict and $12.5 million Wolf verdict demonstrate that juries consider testicular cancer a serious injury meriting substantial compensation, even though survival rates are high. The disruption to a young man's life, the treatment required (orchiectomy, chemotherapy, potential fertility impact), and the emotional toll of a cancer diagnosis in early adulthood are all factors that contribute to damages.
Men who handled AFFF as firefighters or military personnel and have been diagnosed with testicular cancer should consult an attorney even if their treatment was successful and they are in remission. The legal claim is based on the diagnosis and the documented exposure, not on current health status. Past medical expenses, lost wages during treatment, and the physical and emotional suffering caused by the cancer are all compensable.
Scientific Evidence
Meta-Analysis of PFAS Exposure and Cancer Risk: Kidney and Testicular Cancer
Mastrantonio M, Bai E, Uccelli R, Cordiano V, Screpanti A, Corigliano P. (2023). La Medicina del Lavoro
Key Findings
- Relative risk of 1.74 for kidney cancer among individuals with high PFAS exposure compared to low-exposure controls
- Relative risk of 2.22 for testicular cancer among individuals with high PFAS exposure — the strongest relative risk of any PFAS-cancer association
- Dose-response relationship demonstrated: higher PFAS blood levels correlated with progressively higher cancer risk
- Results consistent across multiple study designs and populations, strengthening the causal inference
"The Devil They Knew": Industry Knowledge of PFAS Dangers Since 1970
Brennan NM, Evans AT, Fritz MK, Peak SA, von Holst HE. (2023). Annals of Global Health
Key Findings
- PFAS manufacturers knew about the persistence and toxicity of their products as early as 1970 — more than 50 years before widespread public awareness
- 3M conducted internal studies showing PFAS bioaccumulation in worker blood at 1,000 times normal levels and animal studies showing tumor formation, then classified results as confidential
- Manufacturers used trade secret protections and proprietary research agreements to prevent damaging findings from reaching regulators or the public
- The pattern of corporate concealment parallels the tobacco and asbestos industries and supports punitive damages claims based on willful and malicious conduct
C8 Science Panel: Probable Link Evaluations for PFOA-Associated Diseases
Fletcher T, Savitz D, Steenland K. (2012). Environmental Health Perspectives
Key Findings
- Determined "probable link" between PFOA exposure and six diseases: kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, high cholesterol, and pregnancy-induced hypertension
- Study population of 69,000 residents made it one of the largest PFAS health studies ever conducted, providing exceptional statistical power
- Findings have been cited in virtually every subsequent PFAS lawsuit and regulatory action worldwide
- The "probable link" standard — requiring more than just association but less than definitive proof — was a negotiated scientific threshold that has become the benchmark for PFAS causation evidence
Frequently Asked Questions
Related Pages
3M & DuPont PFAS Lawsuit
3M and DuPont are the two primary defendants in the AFFF/PFAS litigation. 3M manufactured PFOS-based AFFF from the 1960s and has already paid $10.3 billion in water utility settlements and $850 million to Minnesota. DuPont manufactured PFOA and was the target of the landmark Bilott litigation that created the C8 Science Panel. Internal documents from both companies show they knew about PFAS toxicity for decades and concealed it. Their corporate successors — Chemours, Corteva, and others — share in the liability.
AFFF Firefighter Cancer Claims
Firefighters have the highest documented PFAS blood levels of any occupational group and form the core of the AFFF personal injury litigation. Municipal, airport, and military firefighters who trained with AFFF absorbed PFAS through skin contact and inhalation of foam mist, often for years or decades without protective equipment. NIOSH studies show elevated cancer rates among firefighters, and many states have enacted presumptive cancer laws that create favorable conditions for firefighter AFFF claims.
AFFF Kidney Cancer Lawsuit
Kidney cancer (renal cell carcinoma) has the strongest scientific link to PFAS exposure of any cancer. IARC classified PFOA as a Group 1 carcinogen based largely on kidney cancer evidence. Meta-analyses show a relative risk of 1.74 for kidney cancer at high PFAS exposure levels. The C8 Science Panel determined a "probable link" between PFOA and kidney cancer based on the 69,000-person Mid-Ohio Valley study. Firefighters and military personnel with kidney cancer and AFFF exposure history have among the strongest claims in MDL 2873.
AFFF Military Base Contamination
The Department of Defense has identified PFAS contamination at more than 455 military installations where AFFF was used for fire training and emergency response. Air Force bases, Naval air stations, and Marine Corps installations are the most heavily affected. Service members, their families, and surrounding communities were exposed for decades through contaminated drinking water. Military personnel can file AFFF lawsuits against the foam manufacturers while also receiving VA benefits.
AFFF Settlement Amounts
AFFF/PFAS litigation has produced over $12.5 billion in water utility settlements and $670.7 million in C8 personal injury settlements. The personal injury track in MDL 2873 — with 15,216+ claims — is advancing toward bellwether trials that will establish settlement benchmarks. Based on the C8 precedent (averaging ~$189,000 per claim) and the severity of PFAS-linked conditions, projected personal injury settlements range from $25,000 for moderate cases to $2 million or more for severe cases.
AFFF Thyroid Disease Lawsuit
Thyroid disease is one of six conditions with a C8 Science Panel "probable link" to PFOA exposure. PFAS are potent endocrine disruptors that interfere with thyroid hormone synthesis and metabolism, causing hypothyroidism, hyperthyroidism, and thyroid cancer. Thyroid disease is often the earliest clinical manifestation of PFAS exposure and may affect a broader population than PFAS-linked cancers, making it significant for the AFFF litigation.
AFFF Water Contamination Lawsuit
PFAS from AFFF have contaminated the drinking water of an estimated 100 million Americans. Water utility settlements exceeding $12.5 billion have been approved in MDL 2873, but personal injury claims from individuals who drank contaminated water remain active. The EPA's 2024 drinking water standard of 4 ppt for PFOA/PFOS confirmed that previously "safe" levels were actually harmful. Community residents who developed PFAS-linked diseases from contaminated water have viable personal injury claims.
AFFF Firefighting Foam Lawsuit
AFFF firefighting foam containing per- and polyfluoroalkyl substances (PFAS) has been used since the 1960s at military bases, airports, and fire training facilities across the United States. These "forever chemicals" do not break down in the environment and have contaminated groundwater, soil, and drinking water supplies serving millions of Americans. The C8 Science Panel established "probable links" between PFAS exposure and six diseases including kidney cancer, testicular cancer, and thyroid disease. MDL 2873, consolidated before Judge Richard Gergel in the District of South Carolina, encompasses over 15,216 personal injury claims against manufacturers including 3M, DuPont, Chemours, Tyco Fire Products, and BASF. Water utility settlements exceeding $12.5 billion have been approved, and the personal injury track is advancing toward bellwether trials with Daubert motions and expert depositions underway.
View full case overview